Complete Wegovy vs Mounjaro Dosing Guide for UK Buyers
Wegovy and Mounjaro Dose Comparison: Understanding Your Online Purchase Options
When comparing Wegovy and Mounjaro dose structures for online purchase in the UK, the fundamental difference lies in their escalation schedules and mechanisms. Wegovy (semaglutide) follows a 5-step dose escalation over 16 weeks, starting at 0.25mg and reaching maintenance at 2.4mg. Mounjaro (tirzepatide) uses a 4-step escalation over 12 weeks, beginning at 2.5mg and reaching its first maintenance level at 5mg, with options to increase to 10mg or 15mg.
Both treatments require prescription-only medicine status and clinical assessment through our online platform. The key advantage of understanding this wegovy and mounjaro dose comparison before purchase is planning your treatment timeline and budget accordingly. EverydayMeds stocks both options with identical prescription processes, allowing you to switch between treatments if clinically appropriate during your journey.
Wegovy vs Mounjaro Pricing: Complete Dose Comparison Costs
Our wegovy and mounjaro dose comparison reveals different cost structures for each treatment pathway. Wegovy pricing starts with 0.25mg at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to maintenance 2.4mg (£209.99). New customers apply code FIRST40 at checkout to reach these prices, while returning customers use DOSE25.
Mounjaro follows a different pricing model due to its higher starting dose and dual-agonist formulation. When conducting a wegovy and mounjaro dose comparison for budget planning, consider that Wegovy's gentler escalation may suit those preferring gradual introduction, while Mounjaro's approach appeals to those wanting faster progression to therapeutic levels. Both treatments are available through our convenient bundle options, including our Intro Duo (£169.99) and Progress Duo (£189.99) for Wegovy dose escalation phases.
Clinical Evidence Behind Wegovy and Mounjaro Dose Comparison
The wegovy and mounjaro dose comparison extends to their clinical trial evidence and mechanisms of action. Wegovy's STEP programme demonstrated that patients taking the medication alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in STEP 1 trials (Wilding et al., NEJM, 2021). The dose escalation schedule was specifically designed to minimise gastrointestinal side effects while reaching therapeutic effectiveness.
Mounjaro's clinical programme followed a different dose-finding approach due to its dual GIP and GLP-1 receptor agonist mechanism. When comparing wegovy and mounjaro dose schedules, both achieved their primary endpoints through carefully planned escalation, though direct head-to-head comparisons aren't available due to different trial designs and populations. Both treatments are available from EverydayMeds, and your prescriber can help determine which dosing approach aligns with your individual circumstances.
How Wegovy Works: The GLP-1 Mechanism in Dose Comparison Context
Understanding Wegovy's mechanism helps explain why its dose comparison with Mounjaro reveals different approaches to weight management. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural hormone GLP-1 released after eating. This medication works by binding to GLP-1 receptors in the brain's appetite centres, reducing hunger signals and promoting feelings of fullness after smaller meals. The gradual dose escalation from 0.25mg to 2.4mg allows your body to adjust to these appetite-regulating effects while minimising potential side effects. Each weekly injection provides sustained medication levels, which is why the wegovy and mounjaro dose comparison shows Wegovy's once-weekly schedule maintaining consistent appetite suppression. This mechanism, combined with a reduced-calorie diet and increased physical activity, supports sustainable weight management through physiological rather than stimulant-based pathways.
Streamlined Ordering Process for Wegovy and Mounjaro Dose Comparison
Purchasing either treatment through our wegovy and mounjaro dose comparison service follows our established 3-step process designed for UK customers. Begin with our 3-minute online clinical assessment, which evaluates your suitability for either treatment based on BMI, medical history, and weight management goals. Your application then undergoes prescriber review within 3 working days (or 24 hours with express service), where our clinical team determines the most appropriate starting dose and treatment option. Once approved, your medication ships via next-day delivery using cold-chain, temperature-controlled packaging to ensure product integrity. Our GPhC-registered pharmacy (#9012878) ensures you receive genuine Novo Nordisk Wegovy or Eli Lilly Mounjaro, never generic alternatives. This process applies whether you're purchasing individual pens or our convenient bundles designed around each treatment's dose escalation schedule.
Storage and Practical Considerations in Wegovy vs Mounjaro Comparison
The wegovy and mounjaro dose comparison reveals significant differences in storage requirements that affect practical usage. Wegovy pens must be stored in the fridge at 2-8°C before first use, but offer a substantial advantage with 6 weeks of room temperature storage below 30°C once removed from refrigeration. Mounjaro provides only 21 days of room temperature storage, making Wegovy more suitable for frequent travel or situations where refrigeration isn't consistently available. Both treatments use pre-filled injection pens - Wegovy's FlexTouch pen system and Mounjaro's KwikPen - designed for easy once-weekly self-administration. The dose escalation requires multiple pen strengths over time, so planning your prescription timeline ensures you don't run out during critical escalation phases. Each pen contains exactly 4 doses, requiring monthly prescription renewals regardless of which treatment you choose in this wegovy and mounjaro dose comparison.
UK-Specific Wegovy and Mounjaro Dose Availability Comparison
The UK market presents unique considerations when conducting a wegovy and mounjaro dose comparison for online purchase. Wegovy received MHRA approval with all five dose strengths available through licensed UK pharmacies, while Mounjaro's UK availability includes the standard escalation doses through specialist weight management services. EverydayMeds maintains stock levels across both treatment ranges, though supply can fluctuate due to high demand and manufacturing schedules. Our online platform provides real-time availability for each dose strength, allowing you to plan your treatment continuity effectively.
NICE guidance TA875 recommends Wegovy with specialist weight management support, while Mounjaro operates under similar clinical oversight requirements. When comparing wegovy and mounjaro dose options for UK purchase, both require identical clinical assessment standards and ongoing monitoring. Our prescribing team maintains expertise in both treatments, ensuring you receive appropriate clinical guidance regardless of which option proves most suitable for your individual circumstances and treatment goals.
Making Your Wegovy vs Mounjaro Choice: Complete Purchase Guide
Your wegovy and mounjaro dose comparison concludes with practical purchase decisions tailored to UK regulations and your individual needs. Both treatments require prescription-only medicine protocols, clinical assessment, and ongoing monitoring through our platform. New customers should apply code FIRST40 at checkout, while returning customers use DOSE25 to access our competitive pricing structure. Consider starting with single pen purchases to evaluate tolerance before committing to bundle packages, though our Intro Duo and Progress Duo options provide cost-effective dose escalation for those ready to commit to the full programme. Both Wegovy and Mounjaro are available from EverydayMeds with identical service standards, prescription review timelines, and delivery options. Your prescriber will help determine which treatment aligns with your medical history, lifestyle requirements, and weight management goals during the clinical assessment process. Remember that both treatments work alongside a reduced-calorie diet and increased physical activity as part of a comprehensive weight management approach.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
